Lifecore Biomedical, Inc. De (LFCR) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Lifecore Biomedical, Inc. De (NASDAQ:LFCR) is held by 100 institutional firms.

• These investors collectively held 64.7% of the company's total shares outstanding in September 2025, down from 70.5% in June 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by -0.87%, with a year-over-year an increase of 21.95% in the count of filers.
• Of these 100 institutional investors, 48 increased their holdings in Lifecore Biomedical, while 30 of them reduced positions, and 22 investors maintained their exposure.
• This class of investors decreased its holdings in Lifecore Biomedical to 24.34Mn shares for the 13F-cycle ending September 2025, down by 214.79K shares quarter on quarter, and up 3.62Mn shares year over year.
• WYNNEFIELD CAPITAL INC continues to be the largest institutional holder of Lifecore Biomedical as of September 30, 2025, with a position of 4.70Mn shares, representing 12.50% of the company's outstanding stock.
• Among the most significant buyers of Lifecore Biomedical during September 2025 were Squarepoint Ops LLC (119.85K), MARSHALL WACE, LLP (78.72K), MILLENNIUM MANAGEMENT LLC (67.46K), CITADEL ADVISORS LLC (66.75K), JANE STREET GROUP, LLC (66.27K).
• Leading sellers of Lifecore Biomedical stock in September 2025 included Invesco Ltd. (365.81K), 22NW, LP (262.93K), LANDSCAPE CAPITAL MANAGEMENT, L.L.C. (98.59K), BlackRock, Inc. (34.18K), MORGAN STANLEY (30.11K).
• The top 10 institutional holders of Lifecore Biomedical for the quarter ending September 2025 included WYNNEFIELD CAPITAL INC (4.70Mn), Legion Partners Asset Management, LLC (4.46Mn), Greenhaven Road Investment Management, L.P. (3.69Mn), 325 CAPITAL LLC (2.16Mn), BlackRock, Inc. (1.84Mn), VANGUARD GROUP INC (1.62Mn), GEODE CAPITAL MANAGEMENT, LLC (773.63K), GRIZZLYROCK CAPITAL, LLC (738.88K), MORGAN STANLEY (709.70K), STATE STREET CORP (539.28K).